You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PALB2 Mutation

Showing 1 - 25 of 6,468
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Advanced Breast Cancer Trial in Stanford (Talazoparib Tosylate)

Not yet recruiting
  • Breast Cancer
  • Advanced Breast Cancer
  • Talazoparib Tosylate
  • Stanford, California
    Stanford University
Nov 9, 2022

Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2

Recruiting
  • Hereditary Breast and Ovarian Cancer
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Jun 3, 2022

    Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

    Recruiting
    • Pancreatic Adenocarcinoma Metastatic
    • +14 more
    • Boston, Massachusetts
    • +1 more
    Dec 6, 2022

    Pancreatic Cancer Trial in Philadelphia (RUCAPARIB)

    Active, not recruiting
    • Pancreatic Cancer
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Nov 10, 2021

    Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

    Not yet recruiting
    • Metastatic Solid Tumor
    • +4 more
    • San Francisco, California
      University of California, San Francisco
    Jan 12, 2023

    BRCA Mutation, PALB2 Gene Mutation, Ductal Carcinoma in Situ Trial in Italy (drug, other, behavioral)

    Not yet recruiting
    • BRCA Mutation
    • +3 more
    • Tamoxifen 10 Mg Tablet
    • +2 more
    • Genoa, Italy
    • +3 more
    Sep 11, 2023

    Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in United States (Niraparib, Dostarlimab)

    Recruiting
    • Stage I Breast Cancer
    • +7 more
    • Baltimore, Maryland
    • +6 more
    Nov 11, 2022

    ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

    Recruiting
    • ARID1A Gene Mutation
    • +15 more
    • Scottsdale, Arizona
    • +4 more
    Dec 13, 2022

    The Pancreas Interception Center for Early Detection,

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +12 more
    • Data collection
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 11, 2023

    An Intervention to Increase Genetic Testing in Families Who May

    Recruiting
    • BRCA1 Mutation
    • +21 more
    • Intervention Arm At-risk Relative/ARR Contacts
    • +5 more
    • Basking Ridge, New Jersey
    • +7 more
    Nov 22, 2022

    BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston, Seattle (Educational Intervention, Genetic

    Recruiting
    • BARD1 Gene Mutation
    • +14 more
    • Educational Intervention
    • +3 more
    • Houston, Texas
    • +1 more
    Jun 14, 2022

    Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +7 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 21, 2022

    Deleterious BARD1 Gene Mutation, Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation Trial in United States

    Active, not recruiting
    • Deleterious BARD1 Gene Mutation
    • +13 more
    • Laboratory Biomarker Analysis
    • +4 more
    • Chicago, Illinois
    • +8 more
    Feb 25, 2022

    Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Modena (Olaparib 150 MG)

    Recruiting
    • Advanced Pancreatic Cancer
    • Metastatic Pancreatic Cancer
    • Olaparib 150 MG
    • Modena, Italy
      Aou Modena
    Oct 5, 2023

    Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in

    Active, not recruiting
    • Locally Advanced Pancreatic Adenocarcinoma
    • +4 more
    • Biopsy
    • +4 more
    • Chicago, Illinois
    • +11 more
    Jun 28, 2022

    Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

    Not yet recruiting
    • Pancreatic Acinar Cell Carcinoma
    • +6 more
    • Nab paclitaxel
    • +5 more
    • (no location specified)
    Oct 30, 2023

    Breast Cancer Trial in China, Singapore (Prophylactic contralateral breast irradiation)

    Recruiting
    • Breast Cancer
    • Prophylactic contralateral breast irradiation
    • Jiangxi, Jiangxi, China
    • +7 more
    Jul 13, 2021

    HER2-negative Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer Trial in Spain (Olaparib)

    Recruiting
    • HER2-negative Breast Cancer
    • +2 more
    • Barcelona, Spain
    • +4 more
    Apr 14, 2022

    Metastatic Breast Cancer in Germline-PALB2 Mutations Carriers Trial (Niraparib)

    Not yet recruiting
    • Metastatic Breast Cancer in Germline-PALB2 Mutations Carriers
    • (no location specified)
    Feb 21, 2022

    Her-2 Negative Breast Cancer, HRR Gene Mutation Trial in Guangzhou (Camrelizumab, Fluzoparib, Nab-paclitaxel)

    Recruiting
    • Her-2 Negative Breast Cancer
    • HRR Gene Mutation
    • Guangzhou, Guangdong, China
      First Affiliated Hospital, Sun Yat-Sen University
    Mar 7, 2023

    Breast Cancer, Genetic Disease, BRCA2 Mutation Trial (blood sample for BRCA2 mutation detection)

    Not yet recruiting
    • Breast Cancer
    • +2 more
    • blood sample for BRCA2 mutation detection
    • (no location specified)
    Jun 1, 2023

    Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 25, 2022

    AXIN1 Gene Mutation, APC Gene Mutation, Solid Tumor Trial (REC-4881)

    Not yet recruiting
    • AXIN1 Gene Mutation
    • +2 more
    • (no location specified)
    Aug 21, 2023

    Searching for Novel Germline Mutations in Lobular Breast Cancer

    Recruiting
    • Lobular Breast Carcinoma
    • +3 more
    • Illumina panel
    • Milan, Italy
      European Institute of Oncology
    Sep 12, 2022

    Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

    Active, not recruiting
    • Advanced Breast Cancer
    • +2 more
    • Talazoparib Tosylate
    • Stanford, California
      Stanford University Hospitals and Clinics
    Nov 16, 2022